Get our email updates

Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.

Advertisement
Advertisement

Industries

ClearPath launches molecular assay for Group B Strep

SYRACUSE — ClearPath Diagnostics has launched a new women’s health molecular assay for the detection of Group B Streptococcus (GBS) from Meridian Bioscience, Inc. The new assay, named illumigene GBS, is the next generation of technology for GBS testing, ClearPath says. Sensitivity on the new assay approaches 99 percent versus a range of 65 percent

Advertisement

Kaiser Survey: Health premiums grew by less than 5 percent in 2012

Employer-sponsored health-insurance premiums grew more slowly in 2012 than in previous years, but still rose faster than inflation. That’s according to a recent survey from the Kaiser Family Foundation and Health Research and Educational Trust. The national survey found that annual family health-insurance premiums increased 4 percent to $15,745. Premiums for single coverage edged up

Get our email updates

Stay up-to-date on the companies, people and issues that impact businesses in Syracuse, Central New York and beyond.